SeaStar Medical Holding Corp ICU.OQ ICU.O is expected to report resultson May 14 for the period ending March 31 2025
The Denver Colorado-based company is expected to report revenue of $150 thousand, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for SeaStar Medical Holding Corp is for a loss of 52 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00, above its last closing price of $1.25.
This summary was machine generated May 12 at 20:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)